Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
Impact in
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w116981 →Countries where authors are citing Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
This map shows the geographic impact of Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. more than expected).
Fields of papers citing Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
This network shows the impact of Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure..
About Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
This paper, published in 1992, received 461 indexed citations . Written by Pascal Merlet, Héric Valette, J.L. Dubois-Randé, Dominique Moyse, D Duboc, Michel Bourguignon, C Benvenuti, Anne‐Marie Duval and D. Agostini covering the research area of Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Radiology, Nuclear Medicine and Imaging (214 citations), Cardiology and Cardiovascular Medicine (212 citations), Neurology (20 citations), Surgery (17 citations) and Molecular Biology (16 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w116981.